The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Breast cancer metastasis to the bone: mechanisms of bone loss
Open accessAbstract
Breast cancer frequently metastasizes to the skeleton, interrupting the normal bone remodeling process and causing bone degradation. Osteolytic lesions are the end result of osteoclast activity; however, osteoclast differentiation and activation are mediated by osteoblast production of RANKL (receptor activator for NFκB ligand) and several osteoclastogenic cytokines. Osteoblasts themselves are negatively affected by cancer cells as evidenced by an increase in apoptosis and a decrease in proteins required for new bone formation. Thus, bone loss is due to both increased activation of osteoclasts and suppression of osteoblasts. This review summarizes the current understanding of the osteolytic mechanisms of bone metastases, including a discussion of current therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
HADJIDAKIS, D. J., & ANDROULAKIS, I. I. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.035 · Cited by 1,360
Feng, X., & McDonald, J. M. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130203 · Cited by 1,272 · cited 1×
“A thorough review of bone remodeling is beyond the scope of this article, and there are several excellent, recent reviews [8,9].”
BackgroundPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
(2018) · Wiley eBooks · doi:10.1002/9781119266594 · Cited by 1,105
Prostaglandins: Stimulation of Bone Resorption in Tissue Culture
KLEIN, D. C., & RAISZ, L. G. (1970) · Endocrinology · doi:10.1210/endo-86-6-1436 · Cited by 969
Guise, T. A., & Mundy, G. R. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0323 · Cited by 472
Mundy, G. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1546::aid-cncr4>3.0.co;2-i · Cited by 440
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0234 · Cited by 435
Bendre, M. S., Montague, D. C., Peery, T., Akel, N. S., Gaddy, D., & Suva, L. J. (2003) · Bone · doi:10.1016/s8756-3282(03)00086-3 · Cited by 428
Transcription factors controlling osteoblastogenesis
Marie, P. J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.030 · Cited by 387
Bone Remodeling in Post-menopausal Osteoporosis
Lerner, U. H. (2006) · Journal of Dental Research · doi:10.1177/154405910608500703 · Cited by 347
Role of osteopontin in adhesion, migration, cell survival and bone remodeling.
Standal, T., Børset, M., & Sundan, A. (2004) · PubMed · Cited by 346
Repression of Runx2 function by TGF‐β through recruitment of class II histone deacetylases by Smad3
Kang, J. S., Alliston, T., Delston, R., & Derynck, R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600729 · Cited by 344
Breast Cancer Metastasis to Bone: Mechanisms of Osteolysis and Implications for Therapy
Kozlow, W., & Guise, T. A. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-5399-8 · Cited by 337
Raica, M., & Cimpean, A. M. (2010) · Pharmaceuticals · doi:10.3390/ph3030572 · Cited by 304
Lerner, U. H. (2006) · Journal of Dental Research · doi:10.1177/154405910608500704 · Cited by 298
Akech, J., Wixted, J. J., Bedard, K., van der Deen, M., Hussain, S., Guise, T. A., van Wijnen, A. J., Stein, J. L., Languino, L. R., Altieri, D. C., et al. (2010) · Oncogene · doi:10.1038/onc.2009.389 · Cited by 295
Cancer and Inflammation: Implications for Pharmacology and Therapeutics
Balkwill, F., & Mantovani, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.312 · Cited by 249
Clarke, B. L., & Khosla, S. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.02.014 · Cited by 221
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth, J. A., Harb, J. F., Barroso, U., He, Z., Grignon, D. J., & Cher, M. L. (1999) · PubMed · Cited by 221
Role of IGF-I Signaling in Regulating Osteoclastogenesis
Wang, Y., Nishida, S., Elalieh, H. Z., Long, R. K., Halloran, B. P., & Bikle, D. D. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060610 · Cited by 202
Powles, T. J., Clark, S. A., Easty, D. M., Easty, G. C., & Neville, A. M. (1973) · British Journal of Cancer · doi:10.1038/bjc.1973.154 · Cited by 195
Pratap, J., Wixted, J. J., Gaur, T., Zaidi, S. K., Dobson, J., Gokul, K. D., Hussain, S., van Wijnen, A. J., Stein, J. L., Stein, G. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1078 · Cited by 191
Osteoclasts are important for bone angiogenesis
Cackowski, F. C., Anderson, J. L., Patrene, K. D., Choksi, R. J., Shapiro, S. D., Windle, J. J., Blair, H. C., & Roodman, G. D. (2010) · Blood · doi:10.1182/blood-2009-08-237628 · Cited by 188
Parathyroid hormone-related protein and bone metastases
Guise, T. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1572::aid-cncr7>3.0.co;2-m · Cited by 180
Larkins, T. L., Nowell, M., Singh, S., & Sanford, G. L. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-181 · Cited by 175
The molecular mechanism behind bone remodelling: a review
Proff, P., & Römer, P. (2009) · Clinical Oral Investigations · doi:10.1007/s00784-009-0268-2 · Cited by 172
Ganapathy, V., Ge, R., Grazioli, A., Xie, W., Banach-Petrosky, W., Kang, Y., Lonning, S., McPherson, J., Yingling, J. M., Biswas, S., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-122 · Cited by 168
Molecular Mechanisms of Breast Cancer Metastases to Bone
Guise, T. A., Kozlow, W. M., Heras-Herzig, A., Padalecki, S. S., Yin, J. J., & Chirgwin, J. M. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.s.004 · Cited by 167
Bone resorption predicts for skeletal complications in metastatic bone disease
Brown, J. E., Thomson, C. S., Ellis, S. P., Gutcher, S. A., Purohit, O. P., & Coleman, R. E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601437 · Cited by 165
TGF-β in cancer and bone: Implications for treatment of bone metastases
Juárez, P., & Guise, T. A. (2010) · Bone · doi:10.1016/j.bone.2010.08.004 · Cited by 156
Molecular mechanisms underlying osteoclast formation and activation
Troen, B. R. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00069-x · Cited by 155
Bone metastasis: pathogenesis and therapeutic implications
Clézardin, P., & Teti, A. M. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9112-8 · Cited by 151
Vitamin D Deficiency Promotes Human Breast Cancer Growth in a Murine Model of Bone Metastasis
Ooi, L. L., Zhou, H., Kalak, R., Zheng, Y., Conigrave, A. D., Seibel, M. J., & Dunstan, C. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3194 · Cited by 151
Osteoclasts Control Osteoblast Chemotaxis via PDGF-BB/PDGF Receptor Beta Signaling
Sanchez-Fernandez, M. A., Gallois, A., Riedl, T., Jurdic, P., & Hoflack, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003537 · Cited by 144
Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone
Phadke, P. A., Mercer, R. R., Harms, J. F., Jia, Y., Frost, A. R., Jewell, J., Bussard, K. M., Nelson, S. M., Moore, C., Kappes, J. C., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1806 · Cited by 124
Self-citationLipton, A., Uzzo, R. G., Amato, R. J., Ellis, G. K., Hakimian, B., Roodman, G. D., & Smith, M. R. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0080 · Cited by 121
Pozzi, S., Vallet, S., Mukherjee, S., Cirstea, D. D., Vaghela, N., Santo, L., Rosen, E., Ikeda, H., Okawa, Y., Kiziltepe, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0426 · Cited by 117
Immune responses and bone loss: the estrogen connection
Carlsten, H. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00326.x · Cited by 109
Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis
Lynch, C. C. (2010) · Bone · doi:10.1016/j.bone.2010.06.007 · Cited by 103
Metastatic breast cancer induces an osteoblast inflammatory response
Kinder, M., Chislock, E. M., Bussard, K. M., Shuman, L. A., & Mastro, A. M. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.021 · Cited by 102
Self-citationBone Marrow-Derived Cathepsin K Cleaves SPARC in Bone Metastasis
Podgorski, I., Linebaugh, B. E., Koblinski, J. E., Rudy, D., Herroon, M. K., Olive, M. B., & Sloane, B. F. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080906 · Cited by 95
Bone remodeling and its disorders
Mundy, G. R. (1999) · Cited by 94
Bussard, K. M., Venzon, D. J., & Mastro, A. M. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22799 · Cited by 91
Self-citationLipton, A. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.008 · Cited by 91
Breast Cancer Associated Metastasis is Significantly Increased in a Model of Autoimmune ArthritisPreprint
Roy, L. D., Pathangey, L. B., Tinder, T. L., Schettini, J. L., Gruber, H. E., & Mukherjee, P. (2008) · Nature Precedings · doi:10.1038/npre.2008.2632.1 · Cited by 89
Metastatic breast cancer cells suppress osteoblast adhesion and differentiation
Mercer, R. R., Miyasaka, C., & Mastro, A. M. (2004) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-1867-6 · Cited by 86
Self-citationMastro, A. M., & Vogler, E. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4437 · Cited by 80
Self-citationOsteomimicry how tumor cells try to deceive the bone
Teti, A. M. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s110 · Cited by 80
PTH and PTHrP Effects on the Skeleton
Karaplis, A. C., & Goltzman, D. (2000) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1026526703898 · Cited by 77
Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis
Ohshiba, T., Miyaura, C., & Itô, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02937-6 · Cited by 68
Review of Cellular Mechanisms of Tumor Osteolysis
Clohisy, D. R., Perkins, S. L., & Ramnaraine, M. L. R. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200004000-00013 · Cited by 65
Yang, Y., Ren, Y., Ramani, V. C., Nan, L., Suva, L. J., & Sanderson, R. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2179 · Cited by 65
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-07-0234 · Cited by 62
Lee, J., Weber, M. H., Mejia, S., Bone, E. A., Watson, P. H., & Orr, W. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00363-4 · Cited by 60
Zheng, Y., Zhou, H., Modzelewski, J. R. K., Kalak, R., Blair, J. M., Seibel, M. J., & Dunstan, C. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1046 · Cited by 58
New Insights into the Regulation of Cathepsin K Gene Expression by Osteoprotegerin Ligand
Corisdeo, S., Gyda, M., Zaidi, M., Moonga, B. S., & Troen, B. R. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5127 · Cited by 55
Elazar, V., Adwan, H., Bäuerle, T., Rohekar, K., Golomb, G., & Berger, M. R. (2009) · International Journal of Cancer · doi:10.1002/ijc.24890 · Cited by 51
Coenegrachts, L., Maes, C., Torrekens, S., Looveren, R. V., Mazzone, M., Guise, T. A., Bouillon, R., Stassen, J.-M., Carmeliet, P., & Carmeliet, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4092 · Cited by 51
Morrissey, C. M., Lai, J. S., Brown, L. G., Wang, Y.-C., Roudier, M. P., Coleman, I. M., Gulati, R., Vakar‐Lopez, F., True, L. D., Corey, E., et al. (2009) · The Prostate · doi:10.1002/pros.21075 · Cited by 43
The bone remodeling environment is a factor in breast cancer bone metastasis
Ooi, L. L., Zheng, Y., Bilinski, K. L., & Dunstan, C. R. (2010) · Bone · doi:10.1016/j.bone.2010.05.007 · Cited by 35
Resorption of vital or devitalized bone by isolated osteoclasts in vitro
Zallone, A. Z., Teti, A. M., & Primavera, M. V. (1984) · Cell and Tissue Research · doi:10.1007/bf00226953 · Cited by 35
The application of a murine bone bioreactor as a model of tumor: bone interaction
Halpern, J. L., Lynch, C. C., Fleming, J. T., Hamming, D., Martin, M. D., Schwartz, H. S., Matrisian, L. M., & Holt, G. E. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9044-8 · Cited by 31
Mercer, R. R., & Mastro, A. M. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.029 · Cited by 24
Self-citationLipton, A. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181deb9e5 · Cited by 15
Teriparatide for Bone Loss in the Jaw
Grey, A. B. (2010) · New England Journal of Medicine · doi:10.1056/nejme1010459 · Cited by 15
PDGF BB purified from osteoclasts acts as osteoblastogenesis inhibitory factor (OBIF).
Kubota, K., Sakikawa, C., Katsumata, M., Nakamura, T., & Wakabayashi, K. (2002) · PubMed Central · Cited by 9
SKELETAL REACTIONS TO NEOPLASMS
Raisz, L. G., Mundy, G. R., & Luben, R. A. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb14480.x · Cited by 7
Hematologic Malignancies and Bone
Silbermann, R. W., & Roodman, G. D. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch84 · Cited by 6
Chapter 80. Hematologic Malignancies and Bone
McHayleh, W. M., Ellerman, J., & Roodman, G. D. (2008) · Wiley eBooks · doi:10.1002/9780470623992.ch80 · Cited by 2
Chapter 79. Metastatic Solid Tumors to Bone
Mundy, G. R., & Sterling, J. A. R. (2008) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9780470623992.ch79 · Cited by 1
Cited by
Understanding the Bone in Cancer Metastasis
Fornetti, J., Welm, A. L., & Stewart, S. A. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3618 · Cited by 526
Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption
Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Shen, W.-R., Qi, J., Nara, Y., Pramusita, A., Kinjo, R., & Mizoguchi, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145169 · Cited by 380
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease
Liu, H., He, J., Koh, S. P., Zhong, Y., Liu, Z., Wang, Z., Zhang, Y., Li, Z., Tam, B. T., Lin, P., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau9087 · Cited by 113
Alendronate-modified polymeric micelles for the treatment of breast cancer bone metastasis
Liu, T., Romanova, S., Wang, S., Hyun, M. A., Zhang, C., Cohen, S. M., Singh, R. K., & Bronich, T. K. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01343 · Cited by 34
Metadata
- Authors
- Chen, Y.-C., Sosnoski, D. M., & Mastro, A. M.
- Venue
- Breast Cancer Research
- Published
- 2010-12
- Volume
- 12
- Issue
- 6
- Pages
- 215-215
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2132311567
- Cited by
- 282
- References
- 76
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.